Martin J M, Pitetti R, Maffei F, Tritt J, Smail K, Wald E R
Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, PA, USA.
Pediatr Infect Dis J. 2000 Jun;19(6):522-6. doi: 10.1097/00006454-200006000-00006.
Although the recommended standard course of therapy for shigellosis is 5 days of oral ampicillin or trimethoprim-sulfamethoxazole therapy, successful outcome has been reported in adults treated with abbreviated courses of antibiotics. The purpose of this study was to compare short course (2-day) vs. 5-day therapy with cefixime for treatment of diarrheal disease caused by Shigella sonnei in children.
This was a prospective, randomized, double blind, placebo-controlled study. Patients were eligible if they were at least 6 months of age and presented to the Children's Hospital of Pittsburgh during an outbreak of diarrhea caused by S. sonnei, with (1) a history of fever and diarrhea (at least three loose or watery stools per day), (2) bloody diarrhea or (3) diarrhea and known exposure to an individual with documented shigellosis. Patients were randomized to receive either 2 days of cefixime (8 mg/kg(day) given once daily followed by 3 days of placebo or 5 days of cefixime. Telephone follow-up was performed on Days 3, 7 and 14 after enrollment. Follow-up stool cultures were obtained on Day 7 to assess bacteriologic cure. There were standardized definitions for cure, improvement, failure and relapse.
Forty-seven patients were enrolled. Eleven were eliminated from analysis because their stool cultures were not positive for S. sonnei. There were 36 evaluable patients, 21 in the 2-day group and 15 in the 5-day group. Patients ranged in age from 6 months to 17 years. Forty-four percent of the subjects were male. Symptoms were improved or had resolved by Day 3 of therapy in all patients. There were 8 patients who experienced a clinical relapse: 5 of 21 (24%) patients in the 2-day treatment group and 3 of 15 (20%) in the 5-day group. There were 13 patients who experienced a bacteriologic failure (defined as the occurrence of a positive culture at the Day 7 follow-up visit), 11 of 20 (55%) in the 2-day group and 2 of 14 (14%) in the 5-day group (P < 0.02).
Two- and 5-day treatment courses with cefixime for treatment of diarrheal disease caused by S. sonnei result in similar rates of clinical cure and clinical relapses; however, there was a higher rate of bacteriologic failure with shorter course therapy.
虽然志贺氏菌病推荐的标准治疗疗程是口服氨苄青霉素或甲氧苄啶 - 磺胺甲恶唑治疗5天,但已有报道称采用缩短疗程抗生素治疗的成人患者也取得了成功疗效。本研究的目的是比较短疗程(2天)与5天头孢克肟治疗儿童由宋内志贺氏菌引起的腹泻病的效果。
这是一项前瞻性、随机、双盲、安慰剂对照研究。符合条件的患者年龄至少6个月,在匹兹堡儿童医院因宋内志贺氏菌引起的腹泻暴发期间就诊,且具备以下条件之一:(1)有发热和腹泻病史(每天至少3次稀便或水样便),(2)血性腹泻,或(3)腹泻且已知接触过确诊志贺氏菌病的个体。患者被随机分为接受2天头孢克肟治疗组(8毫克/千克/天,每日一次,随后3天服用安慰剂)或5天头孢克肟治疗组。在入组后的第3、7和14天进行电话随访。在第7天采集随访粪便培养物以评估细菌学治愈情况。对治愈、改善、失败和复发有标准化定义。
共纳入47例患者。11例因粪便培养物中宋内志贺氏菌检测为阴性而被排除在分析之外。有36例可评估患者,2天治疗组21例,5天治疗组15例。患者年龄范围为6个月至17岁。44%的受试者为男性。所有患者在治疗第3天时症状均有所改善或已缓解。有8例患者出现临床复发:2天治疗组21例中有5例(24%),5天治疗组15例中有3例(20%)。有13例患者出现细菌学治疗失败(定义为在第7天随访时培养物呈阳性),2天治疗组20例中有11例(55%),5天治疗组14例中有2例(14%)(P<0.02)。
2天和5天头孢克肟治疗疗程用于治疗宋内志贺氏菌引起的腹泻病,临床治愈率和临床复发率相似;然而,短疗程治疗的细菌学治疗失败率较高。